- $2.09bn
- $1.98bn
- $225.21m
Axogen rises after upbeat Q4 results
AxoGen Inc reports results for the quarter ended in December - Earnings Summary
Brief: AxoGen Q4 Adj Net Loss $1.1 Mln
Brief: Axogen, Inc Reports 2022 Fourth Quarter And Full-Year Financial Results
Brief: Axogen Inc - Co Currently Maintains Approximately $8 Million Of Cash With SVB
AxoGen Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Axogen Announces Independent Publication Of Comparative Nerve Gap Repair Meta-Analysis
AxoGen Inc reports results for the quarter ended in September - Earnings Summary
Brief: Axogen Reports Third Quarter Financial Results
AxoGen Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Axogen Announces Appointment Of Adrian Tyndall To Its Board, Retirement Of Founding Director Mark Gold
Brief: Axogen, Inc Reports Second Quarter Financial Results
Brief: Axogen Sees Q2 Revenue Of About $34.4 Million
Brief: Axogen Appoints William Burke To Board Of Directors
AxoGen Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Boeing Co, Rambus Inc, Udemy Inc
U.S. STOCKS ON THE MOVE-Kellogg Co, Fastly Inc, CoreCard Corp
Axogen surges on strong late-stage trial data of nerve graft product
U.S. STOCKS ON THE MOVE-Qorvo Inc, Zoetis Inc, Fisker Inc